Madelon van Agteren

Dr. Madelon van Agteren is a Researcher in the Department of Internal Medicine at Erasmus MC, specializing in nephrology and transplantation medicine. Her work focuses on kidney graft survival, oxalic acid metabolism, and immunosuppressive therapies. She has collaborated on studies analyzing pre-transplant biomarkers like residual diuresis and oxalic acid levels to predict graft outcomes. Her research also addresses delayed graft function, alemtuzumab therapy for severe transplant rejection, and long-term graft failure mechanisms. Key contributions include identifying metabolic and immunological factors influencing transplant success.

Publications highlight innovative approaches in biomarker analysis, with findings published in PLoS ONE, Transplantation, and Frontiers in Medicine. Her work emphasizes translational research bridging clinical practice and molecular mechanisms in organ transplantation.